Picture [LSUS] – The Business Web Portal 600x60px

Persons > Northwestern Switzerland

Find below persons from the region Northwestern Switzerland. Listed are persons from this region as well as persons belonging to organisations located there.

Total search results: 377 | Ordered by Person (ascending)
1 2 3 4  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingRegion
Abend, Sven (Lonza 201903– COO of Lonza Specialty Ingredients segment) President/Director/Head Business Group/Unit/Division Lonza Group (Group) Basel BS
Abraham, Eytan (Lonza 201710 R&D Associate Director) n. a. Lonza Group (Group) Basel BS
Affentranger, Anton (Affentranger Associates 200803 CEO + Senior Partner + founder before Roche CFO) Chief Executive Officer (CEO) Affentranger Associates S.A. Genève (Geneva) GE
Agrawal, Bhuwnesh n. a. Roche (Group) Basel BS
Alldread, Richard (Lonza 201107 Head Technology Development + Strategic Projects at Lonza Development Services) Technical Manager Lonza Group (Group) Basel BS
Allen, Keith (Syngenta Biotechnology Inc. 200604) n. a. Syngenta (Group) Basel BS
Altendorf, Matthias (Endress+Hauser 201609 CEO) Chief Executive Officer (CEO) Endress+Hauser (Group) Reinach BL
Altmeyer, Mark (Arvelle Therapeutics 201902– CEO before Axovant Sciences + BMS + Otsuka America Pharmaceutical) Chief Executive Officer (CEO) Arvelle Therapeutics GmbH Basel BS
Altorfer, Michael (Swiss Biotech Association 201811 CEO before Polyphor + Roche + Ciba-Geigy + Sandoz + UBS Warburg) Chief Executive Officer (CEO) Swiss Biotech Association (SBA) Zürich ZH
Appel, Robert (MCH Group 201207 ILMAC Exhibition Manager) n. a. MCH Group AG Basel BS
Aradhye, Shreeram (Novartis 201801 Global Head of Medical Affairs + CMO) Chief Medical Officer (CMO) Novartis (Group) Basel BS
Attinger, Per-Olof (Roche 199201– Head of Coporate Communication) communication policy Roche (Group) Basel BS
Ayyoubi, Silvia (Roche 200803–201603 Head of Global Human Resources + Member of Corp Executive Committe RETIRED 3/16) Human Resources Manager Roche (Group) Basel BS
Azam, Usman (Oz) (Tmunity Therapeutics 201612– CEO before Novartis + Novaccel + Aspreva + JnJ) Chief Executive Officer (CEO) Tmunity Therapeutics Inc. Philadelphia, PA
Baag, Rima n. a. Genedata (Group) Basel BS
Babiss, Lee E. (Gotham Therapeutics 201810 CEO before Roche+ PPD + Glaxo Wellcome) Chief Executive Officer (CEO) Gotham Therapeutics (Group) New York, NY
Baerlocher, Urs (Novartis –200708) Board member, executive Novartis (Group) Basel BS
Ballmer, Patrick (Sotax 201611 Vice President) President/Director/Head Business Group/Unit/Division Sotax (Group) Allschwil BL
Baltisberger, Matthias M. (Roche 200609 Head of Roche Basel) n. a. Roche (Group) Basel BS
Barrett, Elizabeth (Liz) (UroGen 201901– CEO before CEO Novartis Oncolgoy + Pfizer + Cephalon + JnJ) Chief Executive Officer (CEO) UroGen Pharma Ltd. (Nasdaq: URGN) Ra'anana (Raanana)
Barton, Claire (T3 Pharmaceuticals 201909– CMO before Roche + Lilly + GW) Chief Medical Officer (CMO) T3 Pharmaceuticals AG Basel BS
Bates, Gordon (Lonza 201610 SVP Business Unit Head Chemical + Microbial Manufacturing) President/Director/Head Business Group/Unit/Division Lonza Group (Group) Basel BS
Batra, Udit (Merck (DE) 201507– Head Life Science Business before CEO Merck Millipore + Novartis + JnJ + McKinsey) Chief Executive Officer (CEO) Merck (DE) (Group) Billerica, MA
Batur, Gökhan (Polyphor 201906– CCO before Merck (US)) Chief Commercial Officer (CCO) Polyphor Ltd. (SIX: POLN) Allschwil BL
Batzl-Hartmann, Christine (Pharmacelsus 201110 Managing Director (CEO) + Founder before Novartis) Managing Director Pharmacelsus GmbH Saarbrücken
Bauer, Michael (Cellestia Biotech 201701 CEO) Chief Executive Officer (CEO) Cellestia Biotech AG Basel BS
Baumert, Thomas F. (Univ Stasbourg 201904 Professor + Scientific Founder of Alentis Therapeutics) Professor University of Strasbourg Strasbourg
Bausch, Alexander (Strekin 201705 CEO + Co-Founder) Chief Executive Officer (CEO) Strekin AG Basel BS
Becker, Marc (CRISPR Therapeutics 201603– CFO before rEVO Biologics + Genzyme) Chief Financial Officer (CFO) CRISPR Therapeutics (Group) Basel BS
Beckman, Evan (Novartis 201803 Head of Translational Medicine at Novartis Institutes for BioMedical Research) Research & Development Manager Novartis (Group) Basel BS
Bender, Norbert (Evolva 201105– CMO before ViroLogik + Trigen + Carion + Hoechst + Knoll) Chief Medical Officer (CMO) Evolva (Group) Reinach BL
Benz, Rolf (Sotax Holding 200810 CEO) Chief Executive Officer (CEO) Sotax (Group) Allschwil BL
Biniszkiewicz, Detlev (AstraZeneca 201308 VP Oncology iMed Strategy) Business Development Manager / Strategy Manager AstraZeneca (Group) United Kingdom (town unspecified)
Blatter, Joachim (Basilea 201201– CFO before Swissmetal Industries) Chief Financial Officer (CFO) Basilea (Group) Basel BS
Bodson, Bertrand (Novartis 201801– Chief Digital Officer before Sainsbury’s Argos + EMI + Amazon + Boston Consulting) Chief Information Officer (CIO) / Chief Digital Officer Novartis (Group) Basel BS
Bolzon, Bradley (Versant Ventures 200701 Managing Director) Managing Director Versant Ventures Menlo Park, CA
Bonenberger, Michael (MCH Group 201807 Exhibition Director ILMAC) Event Manager / Conference Manager MCH Group AG Basel BS
Boot, Harry (Lonza 201103–201205 COO Life Science Ingredients sector before Bluestar/Blackstone + GE) Chief Operating Officer (COO) Lonza Group (Group) Basel BS
Borgas, Stefan (Lonza 200610 CEO) Chief Executive Officer (CEO) Lonza Group (Group) Basel BS
Bracht, Franzpeter (Celonic 201711– COO before Glycotope + Aplagen + Ernst & Young + Kienbaum) Chief Financial Officer (CFO) Celonic (Group) Basel BS
Bradner, James E. (Novartis 2016 President Novartis Institutes for BioMedical Research before Broad Institute) Professor Novartis (Group) Basel BS
Braunstein, Guy (Actelion 201108 Head Clinical Development) Clinical Research Manager Johnson & Johnson (JnJ) (Group) Allschwil BL
Breiner, Klaus (BB Biotech Ventures + Vaximm 201605 Executive Chairman) Board member, executive Vaximm (Group) Basel BS
Breu, Raymund (Novartis –2001003 CFO retires 3/10) Chief Financial Officer (CFO) Novartis (Group) Basel BS
Brosch, Markus (Genedata 201905 Business Unit Head for Genedata Expressionist) Product Manager (personnel) Genedata (Group) Basel BS
Bruhn, Heiko (Mediatum 201209 Managing Director of Mediatum Schweiz GmbH) Managing Director Mediatum (Group) Basel BS
Brönnimann, Christian (Dectris 201708 CEO) Chief Executive Officer (CEO) Dectris Ltd. (CH) Baden AG
Bunger, Maureen (Lonza 201703 Product Manager ADME-Tox Solutions) Product Manager (personnel) Lonza Group (Group) Basel BS
Burckhardt, Peter E. (Basel Inkubator 201603 CEO) Chief Executive Officer (CEO) Basel Inkubator (University of Basel + FHNW) Basel BS
Burgermeister, Patrick (Apeiron 201101– Business Development Manager + BioMedPartners before Novartis) Business Development Manager / Strategy Manager Apeiron (Group) Wien (Vienna)
Burgess, Mike (BMS 201301– SVP Discovery Medicine + Clinical Pharmacology before Roche) Research & Development Manager Bristol-Myers Squibb (BMS) (Group) New York, NY
Burns, Robert F. (4-Antibody 201101– CEO before Affitech CEO before Celldex Therapeutics CEO) Chief Executive Officer (CEO) Agenus (Group) Basel BS
Burns, William M. (Roche 200207–200904– CEO Pharma division) Chief Executive Officer (CEO) Roche (Group) Basel BS
Bushell, Mike (Syngenta 200502) n. a. Syngenta (Group) Basel BS
Büttiker, Mathis (Endress+Hauser 201706– Supervisory Board Member main org Notenstein La Roche Privatbank AG) Supervisory Board Member Endress+Hauser (Group) Reinach BL
Cavanagh, Shawn (Lonza Bioscience 200807 President) n. a. Lonza Group (Group) Basel BS
Cawthorn, Robert (Actelion –201109 existent Chairman of Board Directors TO LEAVE BOARD in 2012) Board member, non-executive Johnson & Johnson (JnJ) (Group) Allschwil BL
Clozel, Jean-Paul (Actelion 200607 CEO) Chief Executive Officer (CEO) Johnson & Johnson (JnJ) (Group) Allschwil BL
Clozel, Martine (Actelion 201108 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Johnson & Johnson (JnJ) (Group) Allschwil BL
Cmiljanovic, Vladimir (Piqur Therapeutics 201507 CEO + Co-Founder) Chief Executive Officer (CEO) Piqur Therapeutics AG Basel BS
Colloca, Stefano (Nouscom 201806 CTO) Chief Technology/Technical Officer (CTO) Nouscom (Group) Basel BS
Coppard, Nicholas (Santhera 201502– appointed SVP Head Development) Research & Development Manager Santhera (Group) Liestal BL
Cortese, Riccardo (Nouscom 201605 CEO + Co-Founder before Okairos CEO + co-founder) Chief Executive Officer (CEO) Nouscom (Group) Basel BS
Cowan, Chad (CRISPR Therapeutics 201705 Head of Research) Researcher (industry) CRISPR Therapeutics (Group) Basel BS
Dalle Carbonare, Bruno H. n. a. University of Basel Basel BS
Danne, Doug (Lonza 201010 Head Rapid Testing Solutions business unit) President/Director/Head Business Group/Unit/Division Lonza Group (Group) Basel BS
de Léon, Alethia (Basel (govt) 201702 Managing Director of BaseLaunch) Managing Director Basel (govt city) Basel BS
de Vries, Sijmen (Pharming 200810– CEO before 4-Antibody CEO before Morphochem before Novartis + SKB) Chief Executive Officer (CEO) Pharming (Group) Leiden
Del Fabro, Alessandro (Evolva 201807 VP Finance) Chief Financial Officer (CFO) Evolva (Group) Reinach BL
Devidts, Gilles (SOTAX 201003 Head Product Management) Product Manager (personnel) Sotax (Group) Allschwil BL
Di Nepi, Giacomo (Polyphor 201611– CEO before InterMune + Takeda + McKinsey) Chief Executive Officer (CEO) Polyphor Ltd. (SIX: POLN) Allschwil BL
Ditzinger, Günter (Basilea 201602– promoted CTO joined 2002 before Novartis Pharma + Hoechst Marion Roussel) Chief Technology/Technical Officer (CTO) Basilea (Group) Basel BS
Doherty, Elizabeth (Novartis 201602– Board Director PROPOSED) Board member, non-executive Novartis (Group) Basel BS
Dowdeswell, Christian (Lonza 201902 Head Dosage Forms + Delivery Systesm at Lonza Pharma & Biotech) President/Director/Head Business Group/Unit/Division Lonza Group (Group) Basel BS
Dranoff, Glenn (Novartis 201503– Head of new Immuno-oncology Research Group before Dana Farber) Researcher (industry) Novartis (Group) Basel BS
Dubuis, Olivier (Viollier 201106) n. a. Viollier AG Allschwil BL
Dylan-Hyde, Tyler (CRISPR Therapeutics 201703 Chief Legal Officer) General Counsel / Chief Legal Officer (CLO) CRISPR Therapeutics (Group) Basel BS
Döbelin, Werner (Prolab GmbH 199605– Managing Director + Owner) Managing Director Prolab GmbH (CH) Reinach BL
Ebeling, Thomas (UBS 201711 Standing Member of UBS Oncology Impact Fund former Novartis Pharma CEO) Board member (all kinds of boards: supervisory, advisory, management etc.) UBS (Group) United Kingdom (town unspecified)
Eckhardt, Jürg (Bellevue 201108) Investment Manager Bellevue (Group) Küsnacht ZH
Ehrat, Markus (EK Biosciences GmbH 201203– Managing Director + Co-Founder before Zeptosens CEO) Managing Director EK Biosciences GmbH Aargau (Canton)
Endress, Klaus (Endress+Hauser 201309 CEO) Chief Executive Officer (CEO) Endress+Hauser (Group) Reinach BL
Ernst, Bettina (InterAx Biotech 201901– Non-executive Board Member) Board member, non-executive InterAx Biotech AG Baden AG
Evans, David (Syngenta 200404) n. a. Syngenta (Group) Basel BS
Ewert, Markus L. E. (Alentis Therapeutics 201904– CEO before Ablynx+ GE Healthcare + Novartis + Boston Consulting) Chief Executive Officer (CEO) Alentis Therapeutics AG Basel BS
Fabro, Scott (Evolva 20107– CCO before Sweet Harvest Foods + ACH Foods + Kerry + Cargill) Chief Commercial Officer (CCO) Evolva (Group) Reinach BL
Fallen, Karen (Lonza 201308 VP Licensing + Technology Lonza Development Services) Business Development Manager / Strategy Manager Lonza Group (Group) Basel BS
Fasler, Stephan (Exquiron Biotech AG 201502 CEO) Chief Executive Officer (CEO) Evotec (Group) Reinach BL
Fischer, Karsten (Memo Therapeutics 201806– CEO before BioMedPartners + WestLB) Chief Executive Officer (CEO) BioMedPartners (Group) Basel BS
Fishman, Mark (Novartis Institutes of BioMedical Research 200509 President) President/Director/Head Business Group/Unit/Division Novartis (Group) Basel BS
Flatman, Steve (Lonza 201101 Head Mammalian Development Services) Research & Development Manager Lonza Group (Group) Basel BS
Fleig, Thomas (Valerius Bioharma 201805 CFO before Ernst & Young) Chief Financial Officer (CFO) Valerius Biopharma AG Basel BS
Flintholm Jørgensen, Keld (Lundbeck 201904– EVP + CBO before Roche Global Head of Strategic Partnering) Chief Business Officer (CBO) Lundbeck (Group) København (Copenhagen)
Fowler, Sanna (Lonza 201809 Head PR Lonza Pharma & Biotech) Public Relations Manager / Investor Relations Manager Lonza Group (Group) Basel BS
Foy, Shaun (CRISPR Therapeutics 201404 CFO + Co-Founder + ERS Genomics CEO + Co-Founder before Nomura Phase4 Ventures) Chief Financial Officer (CFO) CRISPR Therapeutics (Group) Basel BS
Franco, Nicholas (Actelion 201106 Chief Business Developm Officer before Axcan Pharma Paris before Novartis Pharma AG) Business Development Manager / Strategy Manager Novartis (Group) Basel BS
Franz, Christoph (Roche 201403– Board Chairman before Lufthansa CEO) Board member, non-executive Roche (Group) Basel BS
French, Hayley (Apitope 201810– COO + interim CEO before CBO + General Counsel since 11/10 before Novartis) Chief Operating Officer (COO) Apitope (Group) Diepenbeek
Friedman, Gary (Novartis 201007 Medical Director – Infectious Disease, Transplantation + Immunology) Chief Medical Officer (CMO) Novartis (Group) Basel BS
Fuchslueger, Ulf (Vialis AG 201105 CEO) Chief Executive Officer (CEO) Vialis (Group) Liestal BL
1 2 3 4  next pagenext page


Picture [LSA] – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

» top